The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial - Results from the BreastSurgANZ National Breast Cancer Audit

被引：19
作者：
Ainsworth, Rachel K. [1 ]
Kollias, James [1 ]
Le Blanc, Abbey [1 ]
De Silva, Primali [2 ]
机构：
[1] Royal Adelaide Hosp, Dept Breast Endocrine & Surg Oncol, Adelaide, SA 5000, Australia
[2] BreastSurgANZ Natl Breast Canc Audit, Adelaide, SA 5006, Australia
来源：
BREAST | 2013年 / 22卷 / 05期
关键词：
Axillary lymph node; Sentinel node biopsy; Z-0011; Early breast cancer; SENTINEL-NODE BIOPSY; IMMUNOHISTOCHEMISTRY;
D O I：
10.1016/j.breast.2012.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Introduction: The publication of the American College of Surgeons Oncology Group (ACOSOG) Z-0011 Trial concluded that axillary lymph node clearance is no longer necessary for women having breast conserving treatment with 1-2 positive axillary sentinel lymph glands. The current study was designed to investigate the clinical impact of the Z-0011 Trial in breast surgical practice. Materials and methods: The BreastSurgANZ National Breast Cancer Audit database was interrogated for women treated between 2005 and 2010 who would have met the entry criteria for the Z-0011 Trial. This group was then calculated as a proportion of the total breast cancer episodes treated during this period. Results: A total of 64,883 cases of breast cancer were eligible for analysis. 22,731 underwent breast conserving surgery and sentinel node biopsy for invasive breast cancer. A total of 4482 cases (6.9%) fulfilled the criteria for Z-11 Trial. Conclusion: Although the ACOSOG Z-0011 Trial has important implications for sentinel node positive cases undergoing breast conserving treatment, the overall impact of the Trial in breast clinical practice is small. It cannot be described as "practice changing". Women who fulfil the entry criteria for the Z-0011 Trial should be informed of the clinical relevance of the trial and be permitted to participate in informed discussions with members of the multidisciplinary team regarding their treatment options. (c) 2012 Published by Elsevier Ltd.
引用
收藏
页码：733 / 735
页数：3
相关论文
共 12 条
[1]   National breast cancer audit: Establishing a web-based data system [J].
Boult, M ;
Cuncins-Hearn, A ;
Tyson, S ;
Kolllias, J ;
Babidge, W ;
Maddern, G .
ANZ JOURNAL OF SURGERY, 2005, 75 (10) :844-847
[2]   Sentinel-Lymph-Node-Based Management or Routine Axillary Clearance? One-Year Outcomes of Sentinel Node Biopsy Versus Axillary Clearance (SNAC): A Randomized Controlled Surgical Trial [J].
Gill, Grantley .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (02) :266-275
[3]   Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases [J].
Giuliano, Armando E. ;
McCall, Linda ;
Beitsch, Peter ;
Whitworth, Pat W. ;
Blumencranz, Peter ;
Leitch, A. Marilyn ;
Saha, Sukamal ;
Hunt, Kelly K. ;
Morrow, Monica ;
Ballman, Karla .
ANNALS OF SURGERY, 2010, 252 (03) :426-433
[4]   Analysis of sentinel node biopsy - a single-institution experience supporting the use of serial sectioning and immunohistochemistry for detection of micrometastases by comparing four different histopathological laboratory protocols [J].
Grabau, Dorthe ;
Ryden, Lisa ;
Ferno, Marten ;
Ingvar, Christian .
HISTOPATHOLOGY, 2011, 59 (01) :129-138
[5]  
Kollias Gill PG, 2001, AUSTR NZ J SURG, V70, P132
[6]   Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial [J].
Krag, David N. ;
Anderson, Stewart J. ;
Bjulian, Thomas ;
Brown, Ann M. ;
Harlow, Seth P. ;
Ashikaga, Takamaru ;
Weaver, Donald L. ;
Miller, Barbara J. ;
Jalovec, Lynne M. ;
Frazier, Thomas G. ;
Noyes, R. Dirk ;
Robidoux, Andre ;
Scarth, Hugh M. C. ;
Mammolito, Denise M. ;
McCready, David R. ;
Mamounas, Eleftherios P. ;
Costantino, Joseph P. ;
Wolmark, Norman .
LANCET ONCOLOGY, 2007, 8 (10) :881-888
[7]  
Leong A S, 2000, Gan To Kagaku Ryoho, V27 Suppl 2, P315
[8]   Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial [J].
Mansel, RE ;
Fallowfield, L ;
Kissin, M ;
Goyal, A ;
Newcombe, RG ;
Dixon, JM ;
Yiangou, C ;
Horgan, K ;
Bundred, N ;
Monypenny, I ;
England, D ;
Sibbering, M ;
Abdullah, TJ ;
Barr, L ;
Chetty, U ;
Sinnett, DH ;
Fleissig, A ;
Clarke, D ;
Ell, PJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (09) :599-609
[9]   Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer [J].
Motomura, K ;
Komoike, Y ;
Inaji, H ;
Hasegawa, Y ;
Kasugai, T ;
Noguchi, S ;
Koyama, H .
BRITISH JOURNAL OF SURGERY, 2002, 89 (08) :1032-1034
[10]  
Pargaonkar AS, 2003, ARCH PATHOL LAB MED, V127, P701
12